- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Ovarian fallopian tube or primary peritoneal cancer
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Olaparib – March 2020
Olaparib: Capsule 50 mg, Tablet 100 mg, Tablet 150 mg; Lynparza®
Last updated
3 July 2020